SMS Pharmaceuticals share news, announcements and annual reports
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
SMS Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2007
Last close ₹485.80up ₹10.35 (2.18%)BSE ₹485.85
Share price at the NSE close on 29 Oct 2026. Previous close ₹475.45.
29 Oct: open ₹477.00, high ₹490.00, low ₹473.00
52-week range of traded prices to 29 Oct 2026
₹270.10Low, 24 Nov 2025₹494.45High, 22 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,550 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,28,71144.6% delivered
SMS Pharmaceuticals orders, deals and press releases
62 filed, newest first. Page 2 of 2.
May 2017
Feb 2017
Nov 2016
16 Nov · Business
Aug 2016
Apr 2016
Jan 2016
Dec 2015
24 Dec · Business
Oct 2008
10 Oct · Business
Press release dated October 10, 2008 titled "World Class Oncology Manufacturing Facility of SMS Pharmaceuticals Inaugurated". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
23 Sep · Business
The Board of Industrial & Financial Reconstruction of India (BIFR) has approved the Modified rehabilitation Scheme vide its order dated 17.09.2008 for the merger of M/s. Plant organics Limited (POL) with M/s SMS Pharmaceuticals Limited with effect from 01.01.2008. The Scheme envisages the company to offset the un-absorbed business losses of the M/s Plant Organics Limited beyond the period of 8 years under the Income-tax Act, 1961 and issuance of shares to the share holders of POL in the exchange ratio of 1: 50 on the Reduced capital of Plant Organics Limited apart from other relief's and concessions
Jul 2008
15 Jul · Business
The Scheme of Amalgamation of Sreenivasa Pharma Pvt. Limited (a wholly owned company) with our Company has been approved by the Hon'ble High Court of A.P., Hyderabad on 19.06.2008
Oct 2007
30 Oct · Business
In the Board Meeting held on October 29, 2007 the Board has taken the following decisions :- 1) Considered for the merger of Sreenivasa Pharma Private Limited (wholly owned subsidiary) with the company.